Filing Details
- Accession Number:
- 0001402051-22-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-10 16:18:29
- Reporting Period:
- 2022-08-08
- Accepted Time:
- 2022-08-10 16:18:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1402051 | William Lewis | 700 Us Highway 202/206 Bridgewater NJ 08807 | Chair And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-08 | 24,430 | $3.40 | 24,430 | No | 4 | M | Indirect | Indirect |
| Common Stock | Disposition | 2022-08-08 | 24,430 | $27.67 | 0 | No | 4 | S | Indirect | Indirect |
| Common Stock | Acquisiton | 2022-08-08 | 6,200 | $3.40 | 6,200 | No | 4 | M | Indirect | Indirect |
| Common Stock | Disposition | 2022-08-08 | 6,200 | $28.45 | 0 | No | 4 | S | Indirect | Indirect |
| Common Stock | Acquisiton | 2022-08-08 | 161,193 | $4.55 | 161,193 | No | 4 | M | Indirect | Indirect |
| Common Stock | Disposition | 2022-08-08 | 161,193 | $27.75 | 0 | No | 4 | S | Indirect | Indirect |
| Common Stock | Acquisiton | 2022-08-08 | 24,977 | $4.55 | 24,977 | No | 4 | M | Indirect | Indirect |
| Common Stock | Disposition | 2022-08-08 | 24,977 | $28.43 | 0 | No | 4 | S | Indirect | Indirect |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Indirect | Indirect |
| No | 4 | S | Indirect | Indirect |
| No | 4 | M | Indirect | Indirect |
| No | 4 | S | Indirect | Indirect |
| No | 4 | M | Indirect | Indirect |
| No | 4 | S | Indirect | Indirect |
| No | 4 | M | Indirect | Indirect |
| No | 4 | S | Indirect | Indirect |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-08-08 | 30,630 | $0.00 | 30,630 | $3.40 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-08-08 | 186,170 | $0.00 | 186,170 | $4.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-09-10 | No | 4 | M | Indirect | |
| 0 | 2022-09-28 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 256,716 | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020
- This is the weighted average sales price representing 24,430 shares sold at prices ranging from $27.26 to $28.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 6,200 shares sold at prices ranging from $28.26 to $28.73 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 161,193 shares sold at prices ranging from $27.26 to $28.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 24,977 shares sold at prices ranging from $28.26 to $28.72 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Billionaire Hedge Funds
